Our website uses cookies which are small bits of data stored as text files on your device. We use these cookies as described in our cookie policy. You can disable or change your cookie settings at any time but parts of our site will not function correctly without them.

IncyteCARES is a program for residents of the United States and Puerto Rico.

Copay card icon

Find out if you qualify for our Copay/Coinsurance Program.*

Eligible patients may pay as little as $0 out-of-pocket for Jakafi® (ruxolitinib).

*Terms and conditions apply. Terms of this program may change at any time.

Two Easy Ways to Get Enrolled in IncyteCARES

ONCE YOU’VE BEEN PRESCRIBED JAKAFI, YOU CAN EITHER:

Call IncyteCARES to get started at 1-855-452-5234

Ask your prescribing Healthcare Professional to enroll you

Note that not all patients who have been prescribed Jakafi are eligible to enroll in IncyteCARES or to receive all services we provide.

THE ENROLLMENT PROCESS HAS 2 PARTS:

ONE FOR YOUR HEALTHCARE PROFESSIONAL. ONE FOR YOU.

Whichever way you choose to start, both you and your Healthcare Professional need to provide information to get you enrolled in IncyteCARES if you’re eligible.

hand with checkmark icon hand with checkmark icon

You provide:

  • The address for monthly delivery of your Jakafi
  • Your insurance information
  • Your financial information (if you want to see if you qualify for the free drug program)
  • Your Patient Authorization for the IncyteCARES program (This means you give permission for your Healthcare Professionals to share your personal medical information with us as part of the program.)

To complete your part, you can:

  • Fill out the enrollment form with your Healthcare Professional
  • Provide your information and verbal authorization over the phone to an IncyteCARES team member
Caduceus medical icon Caduceus medical icon

Your Healthcare Professional provides details about:

  • Your condition
  • Your Jakafi prescription
Telephone icon Telephone icon

WE’LL CALL TO CONFIRM YOUR ENROLLMENT

Once we validate the information you and your Healthcare Professional provide and confirm you’re eligible for IncyteCARES, we will immediately enroll you and let you know by phone that you’ve been enrolled. You can then take advantage of the services and support for which you’re eligible.

On our first call with you, an IncyteCARES representative can:

  • Discuss your insurance coverage for Jakafi
  • Identify financial assistance options that may help you
  • Set up monthly deliveries of your Jakafi
  • Review information about your medicine and more
Telephone icon

NEED HELP?

Our IncyteCARES team is available Monday through Friday, 8 am–8 pm ET

Call us at 1-855-452-5234

INDICATIONS AND USAGE

Jakafi is a prescription medicine used to treat adults with polycythemia vera who have already taken a medicine called hydroxyurea and it did not work well enough or they could not tolerate it.

Jakafi is used to treat adults with certain types of myelofibrosis.

Jakafi is also used to treat adults and children 12 years of age and older with acute graft-versus-host disease (GVHD) who have taken corticosteroids and they did not work well enough.

IMPORTANT SAFETY INFORMATION

JAKAFI CAN CAUSE SERIOUS SIDE EFFECTS, INCLUDING:

Low blood counts: Jakafi® (ruxolitinib) may cause your platelet, red blood cell, or white blood cell counts to be lowered. If you develop bleeding, stop taking Jakafi and call your healthcare provider. Your healthcare provider will perform blood tests to check your blood counts before you start Jakafi and regularly during your treatment. Your healthcare provider may change your dose of Jakafi or stop your treatment based on the results of your blood tests. Tell your healthcare provider right away if you develop or have worsening symptoms such as unusual bleeding, bruising, tiredness, shortness of breath, or a fever.

Infection: You may be at risk for developing a serious infection during treatment with Jakafi. Tell your healthcare provider if you develop any of the following symptoms of infection: chills, nausea, vomiting, aches, weakness, fever, painful skin rash or blisters.

Skin cancers: Some people who take Jakafi have developed certain types of non-melanoma skin cancers. Tell your healthcare provider if you develop any new or changing skin lesions.

Increases in cholesterol: You may have changes in your blood cholesterol levels. Your healthcare provider will do blood tests to check your cholesterol levels during your treatment with Jakafi.

The most common side effects of Jakafi include: for certain types of MF and PV – low platelet or red blood cell counts, bruising, dizziness, headache, and diarrhea; and for acute GVHD – low platelet, red or white blood cell counts, infections, and fluid retention.

These are not all the possible side effects of Jakafi. Ask your pharmacist or healthcare provider for more information. Tell your healthcare provider about any side effect that bothers you or that does not go away.

Before taking Jakafi, tell your healthcare provider about: all the medications, vitamins, and herbal supplements you are taking and all your medical conditions, including if you have an infection, have or had tuberculosis (TB) or have been in close contact with someone who has TB, have or had hepatitis B, have or had liver or kidney problems, are on dialysis, high cholesterol or triglycerides, had skin cancer, or have any other medical condition. Take Jakafi exactly as your healthcare provider tells you. Do not change your dose or stop taking Jakafi without first talking to your healthcare provider.

Women should not take Jakafi while pregnant or planning to become pregnant. Do not breastfeed during treatment with Jakafi and for 2 weeks after the final dose.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

You may also report side effects to Incyte Medical Information at 1-855-463-3463.